SCHEMBL7674151

SCHEMBL7674151

CC1=NN=C(c2ccncc2)[N]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
LMNA P02545 1/20 0.43
NOTUM Q6P988 1/20 0.37
KIF11 P52732 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PABPC1 P11940 1/20 0.35
APOBEC3A P31941 1/20 0.35
EIF4H Q15056 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
GAA P10253 1/20 0.34
FLT3 P36888 2/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
DDAH1 O94760 1/20 0.33
NOS1 P29475 1/20 0.33
KDM4E B2RXH2 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7682675 0.66 ESR2 (0.43) NOTUMSMN1; SMN2GAATP53CYP1A2
Ethane SCHEMBL27940957 0.65 MAPT (0.85) MAPTLMNANOTUMKIF11SMN1; SMN2
SCHEMBL9728 0.64 MAPT (1.00) MAPTLMNANOTUMKIF11SMN1; SMN2
SCHEMBL16694778 0.64 MAPT (0.69) MAPTLMNANOTUMKIF11SMN1; SMN2
SCHEMBL7682426 0.64 TSHR (0.40) MAPTSMN1; SMN2CYP1A2CYP3A4CYP2D6
SCHEMBL7678568 0.64 KDM4E (0.50) MAPTLMNASMN1; SMN2FLT3TP53
SCHEMBL7676234 0.64 CYP1A2 (0.40) GAAKDM4ECYP1A2CYP3A4CYP2D6
Methyl Alcohol SCHEMBL28030205 0.63 MAPT (0.79) MAPTLMNANOTUMKIF11SMN1; SMN2
SCHEMBL13019480 0.62 MAPT (0.65) MAPTLMNANOTUMKIF11SMN1; SMN2
SCHEMBL21652623 0.62 MAPT (0.56) MAPTLMNANOTUMKIF11SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP claimed
JP-3110467-B2 2000-11-20 JP claimed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP claimed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO claimed
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed